สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioødemer, arvelig - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
นอร์เวย์ -
นอร์เวย์ -
Statens legemiddelverk
bupivacaine baxter 2.5 mg/ ml
baxter holding b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 2.5 mg/ ml
นอร์เวย์ -
นอร์เวย์ -
Statens legemiddelverk
bupivacaine baxter 5 mg/ ml
baxter holding b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psykoleptika, hypnotika og sedativer - hunder - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
evra
gedeon richter plc. - norelgestromin, ethinyl estradiol - prevensjon - sex hormoner og modulatorer av genital systemet, - kvinne prevensjon. evra er beregnet for kvinner i fruktbar alder. sikkerhet og effekt er etablert i kvinner i alderen 18 til 45 år.
สหภาพยุโรป -
นอร์เวย์ -
EMA (European Medicines Agency)
gliolan
photonamic gmbh & co. kg - 5-aminolevulinsyre hydroklorid - gliom - antineoplastiske midler - gliolan er indisert hos voksne pasienter for visualisering av ondartet vev under operasjon for ondartet gliom (verdens helseorganisasjon iii og iv).